Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP7LP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,442
Award facts
- Contract value 100% obligated
- $15,441.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,441.58 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and inflammatory bowel disease, reflecting the Defense Health Agency's pharmaceutical procurement needs for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As one of the federal government's primary pharmaceutical distributors, AmerisourceBergen serves critical supply chain functions for military healthcare systems globally, delivering a comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical supplies. The company's substantial IDC with DLA demonstrates its established capacity to fulfill federal medical procurement requirements across multiple therapeutic domains and geographic regions supporting the Defense Health Agency and other military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FP7LP?
SPE2DR26FP7LP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FP7LP worth?
The government has obligated $15,442 on SPE2DR26FP7LP.
Is contract SPE2DR26FP7LP an order under another contract?
Yes. SPE2DR26FP7LP is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP7LP competed?
The extent of competition for SPE2DR26FP7LP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award